Tim Noteboom$13.1MFollowers@tboomer06/08/2023Bought 54% more NVCRNovoCure at $44.97 1 0123456789Nathan Worden@nathanworden06/08/2023Are you thinking the market is overreacting to the LUNAR study? Seemed like the results weren’t that bad. Just that the standard of care changed while the study was occurring. Add a comment…
Nathan Worden@nathanworden06/08/2023Are you thinking the market is overreacting to the LUNAR study? Seemed like the results weren’t that bad. Just that the standard of care changed while the study was occurring. Add a comment…
